HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rikio Yoshimura Selected Research

Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)

4/2009Relationship between cysteinyl-leukotriene-1 receptor and human transitional cell carcinoma in bladder.
3/2009Expression of cysteinylLT1 receptor in human testicular cancer and growth reduction by its antagonist through apoptosis.
7/2008The role of arachidonic acid in a rat renal ischemia-reperfusion injury model.
3/2008The cysteinylLT1 receptor in human renal cell carcinoma.
1/2008Feedback Control of the Arachidonate Cascade in Osteoblastic Cells by 15-deoxy-Delta-Prostaglandin J(2).
7/2007Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
10/2005[Relationship between cyclooxygenase (COX)-2 and malignant tumors].
7/20055-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
6/2004The effects of cyclooxygenase-2 inhibitors on urological cancer cells.
4/2004Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rikio Yoshimura Research Topics

Disease

23Neoplasms (Cancer)
03/2010 - 05/2002
14Prostatic Neoplasms (Prostate Cancer)
01/2012 - 05/2002
11Renal Cell Carcinoma (Grawitz Tumor)
03/2010 - 12/2003
11Carcinogenesis
03/2010 - 10/2005
9Urinary Bladder Neoplasms (Bladder Cancer)
03/2010 - 05/2003
9Testicular Neoplasms (Testicular Cancer)
03/2010 - 09/2002
8Reperfusion Injury
03/2010 - 02/2002
7Urologic Neoplasms (Urological Cancer)
03/2010 - 12/2003
5Colorectal Neoplasms (Colorectal Cancer)
12/2009 - 10/2005
4Carcinoma (Carcinomatosis)
06/2004 - 05/2003
3Rheumatoid Arthritis
09/2008 - 01/2005
3Ischemia
07/2008 - 07/2008
2Lower Urinary Tract Symptoms
03/2015 - 01/2012
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2012 - 07/2007
2Bone Resorption
04/2009 - 01/2008
2Necrosis
07/2008 - 12/2004
2Inflammation (Inflammations)
03/2006 - 01/2005
2Disease Progression
02/2006 - 10/2002
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
02/2006 - 10/2002
2Neoplasm Metastasis (Metastasis)
01/2004 - 11/2003
1Nocturia
03/2015
1Chronic Kidney Failure (Chronic Renal Failure)
01/2011
1Bone Diseases (Bone Disease)
04/2009
1Transitional Cell Carcinoma
04/2009
1Osteoporosis
01/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2007
1Prostatic Intraepithelial Neoplasia
07/2007
1Sepsis (Septicemia)
02/2006
1Critical Illness (Critically Ill)
02/2006
1Hepatolenticular Degeneration (Wilson's Disease)
01/2005
1Cachexia
01/2005
1Arthritis (Polyarthritis)
01/2005
1Heart Arrest (Cardiac Arrest)
12/2004
1Cystitis
11/2003
1Arteriosclerosis
03/2003
1Pathologic Constriction (Stenosis)
03/2003
1Sudden Death
03/2003

Drug/Important Bio-Agent (IBA)

15Arachidonic Acid (Vitamin F)IBA
12/2009 - 11/2003
15Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
04/2009 - 01/2003
12LigandsIBA
03/2010 - 05/2002
12Lipoxygenase (Lipoxygenase-1)IBA
07/2009 - 11/2003
10Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2010 - 05/2002
7EnzymesIBA
12/2009 - 06/2004
7PPAR gammaIBA
12/2008 - 05/2002
5leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
03/2010 - 07/2007
5Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2009 - 10/2005
5EicosanoidsIBA
07/2008 - 11/2003
3Telmisartan (Micardis)FDA Link
03/2010 - 08/2008
3CytokinesIBA
07/2008 - 10/2002
3Lipoxygenase InhibitorsIBA
07/2005 - 11/2003
3OligodeoxyribonucleotidesIBA
12/2004 - 09/2002
3Thromboplastin (Tissue Factor)IBA
09/2003 - 02/2002
2LeukotrienesIBA
07/2009 - 04/2009
2Peptides (Polypeptides)IBA
02/2004 - 01/2003
2Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
01/2004 - 11/2003
2Antisense OligonucleotidesIBA
09/2003 - 09/2002
2PPAR alphaIBA
05/2003 - 09/2002
1naftopidilIBA
03/2015
1eviprostatIBA
01/2012
1AntioxidantsIBA
01/2012
1Phosphates (Orthophosphate)IBA
03/2010
1Cytostatic AgentsIBA
04/2009
1Zoledronic Acid (Zometa)FDA Link
04/2009
1Mevalonic Acid (Mevalonate)IBA
04/2009
1NitrogenIBA
04/2009
1Pamidronate (Aredia)FDA LinkGeneric
04/2009
1Androgen Receptors (Androgen Receptor)IBA
04/2009
1Diphosphonates (Bisphosphonates)IBA
04/2009
1TransferasesIBA
01/2009
1Messenger RNA (mRNA)IBA
01/2009
1Hormones (Hormone)IBA
01/2009
1Eicosapentaenoic AcidIBA
09/2008
1Leukocyte Elastase (Neutrophil Elastase)IBA
07/2008
1Secretory Proteinase Inhibitory ProteinsIBA
07/2008
1ProstaglandinsIBA
01/2008
1Prostaglandins EIBA
01/2008
1InterleukinsIBA
01/2008
1Interleukin-1 (Interleukin 1)IBA
01/2008
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
03/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2006
1Interleukin-8 (Interleukin 8)IBA
02/2006
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2006
1Interleukin-6 (Interleukin 6)IBA
02/2006
1Troglitazone (Rezulin)FDA Link
04/2005
1CopperIBA
01/2005
1Pharmaceutical PreparationsIBA
01/2005
1tetrathiomolybdate (ammonium tetrathiomolybdate)IBA
01/2005
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2004
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2004
1BromidesIBA
11/2003
1Dihydrotachysterol (AT 10)IBA
03/2003

Therapy/Procedure

5Therapeutics
01/2011 - 11/2002
3Renal Dialysis (Hemodialysis)
01/2011 - 01/2003
2Kidney Transplantation
07/2008 - 08/2007
2Hemoperfusion
02/2006 - 10/2002
1Brachytherapy
01/2012
1Transplantation
12/2004
1Ureterostomy
06/2004
1Lymph Node Excision (Lymph Node Dissection)
06/2004
1Catheters
03/2003